Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.

Saved in:
Bibliographic Details
Title: Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.
Authors: Lenferink AEG; Medical Devices Research Centre, National Research Council Canada, Montréal, QC, Canada., Zwaagstra JC; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Baardsnes J; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Delafosse L; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Parat M; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Iqbal U; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada., Lessard E; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Haqqani AS; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada., Jezierski A; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.; Department of Medicine, Goodman Cancer Institute, McGill University, Montréal, QC, Canada., Abu-Thuraia A; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Tabariès S; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Siegel PM; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Sulea T; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.; Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, QC, Canada.
Source: Frontiers in oncology [Front Oncol] 2025 Oct 27; Vol. 15, pp. 1648779. Date of Electronic Publication: 2025 Oct 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1648779